• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明硫酸乙酰肝素酶2与硫酸乙酰肝素结合的后果。

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.

作者信息

Gross-Cohen Miriam, Feld Sari, Arvatz Gil, Ilan Neta, Vlodavsky Israel

机构信息

Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel.

出版信息

Front Oncol. 2021 Jan 29;10:627463. doi: 10.3389/fonc.2020.627463. eCollection 2020.

DOI:10.3389/fonc.2020.627463
PMID:33585253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7879983/
Abstract

Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly indicates that Hpa2 is not a pseudogene but rather a gene coding for an important protein. Hpa2 lacks the heparan sulfate (HS)-degrading activity typical of heparanase, yet exhibits high affinity to HS, affinity that is 10-fold higher than that of heparanase. The consequences of this high-affinity interaction of Hpa2 with plasma membrane HSPG has not been explored yet. Here, we used highly purified Hpa2 protein to examine this aspect. We provide evidence that cells adhere to and spread on dishes coated with Hpa2. We also show that cell migration is attenuated markedly by exogenous addition of Hpa2 to primary and transformed cells, a function that agrees with the anti-cancer properties of Hpa2. Interestingly, we found that exogenous addition of Hpa2 also disrupts the morphology of cell colonies, resulting in cell scattering. This implies that under certain conditions and experimental settings, Hpa2 may exhibit pro-tumorigenic properties. We further developed a panel of anti-Hpa2 monoclonal antibodies (mAb) and show that these properties of Hpa2 are prevented by some of the newly-developed mAb, thus providing new molecular tools to better appreciate the significance of Hpa2 in health and disease.

摘要

与致力于探索乙酰肝素酶在人类疾病中意义的大量研究工作不同,其紧密同源物乙酰肝素酶2(Hpa2)却很少受到关注。Hpa2在一种罕见的常染色体隐性先天性疾病——尿路颜面综合征(UFS)中所起的新作用,清楚地表明Hpa2不是一个假基因,而是一个编码重要蛋白质的基因。Hpa2缺乏乙酰肝素酶典型的硫酸乙酰肝素(HS)降解活性,但对HS表现出高亲和力,其亲和力比乙酰肝素酶高10倍。Hpa2与质膜硫酸乙酰肝素蛋白聚糖(HSPG)这种高亲和力相互作用的后果尚未得到探索。在此,我们使用高度纯化的Hpa2蛋白来研究这一方面。我们提供的证据表明,细胞能黏附于涂有Hpa2的培养皿并在其上铺展。我们还表明,向原代细胞和转化细胞中外源添加Hpa2会显著减弱细胞迁移,这一功能与Hpa2的抗癌特性相符。有趣的是,我们发现外源添加Hpa2还会破坏细胞集落的形态,导致细胞散射。这意味着在某些条件和实验设置下,Hpa2可能表现出促肿瘤特性。我们进一步研制了一组抗Hpa2单克隆抗体(mAb),并表明其中一些新研制的mAb可阻止Hpa2的这些特性,从而提供了新的分子工具,以便更好地理解Hpa2在健康和疾病中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/cf96a1b42747/fonc-10-627463-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/0e6f4a168e31/fonc-10-627463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/85dec8acd26b/fonc-10-627463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/881ee7633255/fonc-10-627463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/c11393cb1f93/fonc-10-627463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/9459d017f67f/fonc-10-627463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/cf96a1b42747/fonc-10-627463-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/0e6f4a168e31/fonc-10-627463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/85dec8acd26b/fonc-10-627463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/881ee7633255/fonc-10-627463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/c11393cb1f93/fonc-10-627463-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/9459d017f67f/fonc-10-627463-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/cf96a1b42747/fonc-10-627463-g006.jpg

相似文献

1
Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.阐明硫酸乙酰肝素酶2与硫酸乙酰肝素结合的后果。
Front Oncol. 2021 Jan 29;10:627463. doi: 10.3389/fonc.2020.627463. eCollection 2020.
2
Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.肝素酶-2 (Hpa2) 对癌症和炎症的影响:进展与模式。
FASEB J. 2024 May 31;38(10):e23670. doi: 10.1096/fj.202400286R.
3
A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.乙酰肝素酶2(Hpa2)在甲状腺癌中的促肿瘤作用涉及其定位于核膜。
Front Oncol. 2021 Apr 20;11:645524. doi: 10.3389/fonc.2021.645524. eCollection 2021.
4
Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.乙酰肝素酶2可减弱头颈肿瘤的血管生成及生长。
Cancer Res. 2016 May 1;76(9):2791-801. doi: 10.1158/0008-5472.CAN-15-1975. Epub 2016 Mar 24.
5
Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.肝素酶 2(Hpa2)-胰腺腺泡细胞分化的新关键因子。
Cell Death Dis. 2023 Jul 25;14(7):465. doi: 10.1038/s41419-023-05990-y.
6
Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.应激诱导乙酰肝素酶 2(Hpa2)的表达是由 ATF3 介导的。
Matrix Biol. 2022 Jan;105:17-30. doi: 10.1016/j.matbio.2021.11.001. Epub 2021 Nov 20.
7
Role of heparanase 2 (Hpa2) in gastric cancer.乙酰肝素酶 2(Hpa2)在胃癌中的作用。
Neoplasia. 2021 Sep;23(9):966-978. doi: 10.1016/j.neo.2021.07.010. Epub 2021 Jul 31.
8
Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.乙酰肝素酶2(Hpa2)通过诱导Sox2表达来减弱肿瘤生长。
Matrix Biol. 2021 May;99:58-71. doi: 10.1016/j.matbio.2021.05.001. Epub 2021 May 15.
9
Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.乙酰肝素酶——一种具有多种酶促和非酶促功能的单一蛋白质。
Proteoglycan Res. 2023 Jul 1;1(3):e6. doi: 10.1002/pgr2.6. Epub 2023 Jul 9.
10
Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.乙酰肝素酶 2 与硫酸乙酰肝素具有高亲和力,并抑制乙酰肝素酶活性。
J Biol Chem. 2010 Sep 3;285(36):28010-9. doi: 10.1074/jbc.M110.116384. Epub 2010 Jun 24.

引用本文的文献

1
Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization.肿瘤源性和宿主源性乙酰肝素酶-2(Hpa2)减弱肿瘤发生能力:Hpa2在巨噬细胞极化和BRD7核定位中的作用
Cell Death Dis. 2024 Dec 18;15(12):894. doi: 10.1038/s41419-024-07262-9.
2
Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis.肝素酶 2(Hpa2)的核定位可减弱乳腺癌的生长和转移。
Cell Death Dis. 2024 Mar 22;15(3):232. doi: 10.1038/s41419-024-06596-8.
3
Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective.

本文引用的文献

1
Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19.新型冠状病毒肺炎重症患者的内皮糖萼损伤
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1178-1181. doi: 10.1164/rccm.202007-2676LE.
2
Heparanase, cell signaling, and viral infections.肝素酶、细胞信号转导与病毒感染。
Cell Mol Life Sci. 2020 Dec;77(24):5059-5077. doi: 10.1007/s00018-020-03559-y. Epub 2020 May 27.
3
COVID-19: the vasculature unleashed.COVID-19:血管失控。
乙酰肝素酶可能是猴痘和新冠病毒之间的联系:从神秘角度和当前视角来看有力的候选因素
AMB Express. 2023 Jan 27;13(1):13. doi: 10.1186/s13568-023-01517-y.
4
Expanding the Genotypic Spectrum in Urofacial Syndrome, A Disease Featuring a Peripheral Neuropathy of the Urinary Bladder.扩展膀胱外周神经病变相关疾病——面尿综合征的基因谱
Front Genet. 2022 Jun 23;13:896125. doi: 10.3389/fgene.2022.896125. eCollection 2022.
5
Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.应激诱导乙酰肝素酶 2(Hpa2)的表达是由 ATF3 介导的。
Matrix Biol. 2022 Jan;105:17-30. doi: 10.1016/j.matbio.2021.11.001. Epub 2021 Nov 20.
6
A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.乙酰肝素酶2(Hpa2)在甲状腺癌中的促肿瘤作用涉及其定位于核膜。
Front Oncol. 2021 Apr 20;11:645524. doi: 10.3389/fonc.2021.645524. eCollection 2021.
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
4
Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.肝素酶和肝素酶-2在头颈部癌症中的相反作用。
Adv Exp Med Biol. 2020;1221:847-856. doi: 10.1007/978-3-030-34521-1_37.
5
Heparanase: A Dynamic Promoter of Myeloma Progression.肝素酶:多发性骨髓瘤进展的动态促进剂。
Adv Exp Med Biol. 2020;1221:331-349. doi: 10.1007/978-3-030-34521-1_12.
6
Heparanase: Historical Aspects and Future Perspectives.肝素酶:历史方面和未来展望。
Adv Exp Med Biol. 2020;1221:71-96. doi: 10.1007/978-3-030-34521-1_3.
7
Forty Years of Basic and Translational Heparanase Research.四十年肝素酶基础与转化研究
Adv Exp Med Biol. 2020;1221:3-59. doi: 10.1007/978-3-030-34521-1_1.
8
Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src.乙酰肝素酶通过激活Src蛋白来松解E-钙黏蛋白介导的细胞间接触。
Front Oncol. 2020 Jan 22;10:2. doi: 10.3389/fonc.2020.00002. eCollection 2020.
9
Heparanase: A Challenging Cancer Drug Target.乙酰肝素酶:一个具有挑战性的癌症药物靶点。
Front Oncol. 2019 Nov 28;9:1316. doi: 10.3389/fonc.2019.01316. eCollection 2019.
10
Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.肝素酶与化疗协同作用驱动巨噬细胞活化并增强肿瘤生长。
Cancer Res. 2020 Jan 1;80(1):57-68. doi: 10.1158/0008-5472.CAN-19-1676. Epub 2019 Nov 5.